Dr. Gradinaru's lab recently developed capsids capable of crossing the blood-brain barrier, enabling noninvasive delivery of sensors and actuators to the CNS in transgenic and non-transgenic animals. With synergistic developments in actuators, systemic Adeno-associated viruses (AAVs) will allow researchers to modulate defined cell types and circuits across multiple deep-brain structures in a minimally invasive manner and test the behavioral effects of this modulation in animal models.
Is this you? Claim this profile →
No public contact links on file.
Speaking history
Neuroscience
Neuroscience
Neuroscience
Topics this speaker covers
Sectors
Sourcing speakers for your event?
Browse the speaker directory →